Tilray Brands Inc (TLRY)
3.00
+0.13 (+4.53%)
USD |
NASDAQ |
Oct 04, 16:00
3.02
+0.02 (+0.67%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.828B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -74.26% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.275 |
| Price to Book Value | 0.4156 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1377 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
MT Newswires
09/30 11:02
SA Breaking News
09/30 10:45
Yahoo
09/30 07:01
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 10/07/2022 | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 10/06/2022 | -- | Results | Q1 2023 | -- | -0.07 | -- | |
| 07/28/2022 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 07/27/2022 | -- | Results | Q4 2022 | -0.07 | -0.08 | 14.88% | |
| 04/06/2022 | -- | Results | Q3 2022 | 0.07 | -0.08 | 193.8% | |
| 04/06/2022 | 08:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 01/10/2022 | -- | Results | Q2 2022 | -- | -0.08 | -- | |
| 01/10/2022 | 08:30 EST | Earnings Call | Q2 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. |
| URL | https://www.tilray.com |
| Investor Relations URL | https://ir.tilray.com/ |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Oct. 06, 2022 |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of October 03, 2022.
Fundamentals
| Revenue (TTM) | 628.37M |
| Total Expenses (TTM) | 878.39M |
| Net Income (TTM) | -476.80M |
| Total Assets (Quarterly) | 5.450B |
| Total Liabilities (Quarterly) | 1.008B |
| Shareholders Equity (Quarterly) | 4.399B |
| Cash from Operations (TTM) | -177.26M |
| Cash from Investing (TTM) | -21.53M |
| Cash from Financing (TTM) | 128.20M |
Ratings
Profile
Edit
| Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. |
| URL | https://www.tilray.com |
| Investor Relations URL | https://ir.tilray.com/ |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Oct. 06, 2022 |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| TLRY Tweets |